These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Multifocal electroretinography, color discrimination and ocular toxicity in tamoxifen use. Salomão SR; Watanabe SE; Berezovsky A; Motono M Curr Eye Res; 2007 Apr; 32(4):345-52. PubMed ID: 17453956 [TBL] [Abstract][Full Text] [Related]
17. To stop or not? Tamoxifen therapy for secondary prevention of breast cancer in a patient with ocular toxicity. Bommireddy T; Carrim ZI BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26759403 [TBL] [Abstract][Full Text] [Related]
18. [Tamoxifen retinopathy: a case series of clinical and functional data]. Ritter C; Renner AB; Wachtlin J; Bechrakis NE; Krause L Ophthalmologe; 2008 Jun; 105(6):544-9. PubMed ID: 18415107 [TBL] [Abstract][Full Text] [Related]
19. Tamoxifen retinopathy. A case report. Costa RH; Dhooge MR; Van Wing F; De Rouck AF Bull Soc Belge Ophtalmol; 1990; 238():161-8. PubMed ID: 2131119 [TBL] [Abstract][Full Text] [Related]
20. [Electrophysiological studies in breast carcinoma patients with tamoxifen retinopathy]. Kuchenbecker J; Pump-Schmidt C; Olbricht S; Weise W; Behrens-Baumann W Ophthalmologe; 2001 Jan; 98(1):81-5. PubMed ID: 11220276 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]